Elizabeth A Grammer insider trades

Open-market stock purchases and sales by Elizabeth A Grammer, Director at Sagimet Biosciences Inc, from SEC Form 4 filings since Jan 6, 2015.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -49%.

Recent trades

DateStockTradeValue
Jun 12, 2026SGMT Sagimet Biosciences IncBought (not open market)—
Nov 21, 2025ARDX Ardelyx, IncSold$33.2K

Companies traded

  • SGMT Sagimet Biosciences Inc: other filings, last Jun 12, 2026
  • ARDX Ardelyx, Inc: 2 buys, 55 sales, last Nov 21, 2025

Get free alerts when Elizabeth A Grammer files a new trade →